Main > ONCOLOGY (**) > Lung>NSCLC>EGFR+>MET>*** > Treatment > Co: DE. B. Afatinib Tablets ***

---

Co: DE. B. Afatinib Tablets ***'s subsections
(*) EU Approval Date: 2013. 09.25.
(*) USA Approval Date: 2018. 01.16.
Companion Diagnostics>
Company
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 3
Patent>UpDate: 2018. 10.23.
Patent>UpDate: 2018. 10.23.
TradeMark
TradeMark Web-Site
UpDate: 2017. 10.23.

Co: DE. B. Afatinib Tablets ***'s products
This section has no products